EN | RU
EN | RU

Help Support

Back
Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis
Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis Tralokinumab: A review on its efficacy, safety, and tolerability in treatment of atopic dermatitis

Atopic dermatitis (or eczema) is one of the most common heterogeneous inflammatory skin diseases. 

See All

Attachment
Previous

Next
Risk assessment of rituximab usage and COVID-19 infection in patients with MS and NMOSD

Comments (0)

Recommendations

Read
Watch

Diet rich in polyunsaturated fatty acid, protein and fibres slash...

Labetalol found safer and more tolerable than Nifedipine in preec...

Medically supervised prolonged fasting boosts patient outcomes in...

FDA nods for Resmetirom, first-of-its-kind liver scarring treatme...

Efficacy and safety of nonsteroidal anti-inflammatory drugs in As...

An introduction to pain pathways and mechanisms

Thank you for your participation!

Association between pain, central sensitization and anxiety in po...

Related Tags
Next
201

Risk assessment of rituximab usage and COVID-19 infection in pati...

Summaries

Selecting a safe disease modifying therapy (DMT) during the COVID-19 is perplexing. This analytical case series study was aimed to find the incid...

3 min More details
You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en ua
Try:

This website uses cookies to help us give you the best experience when you visit.

By using this website you consent to our use of cookies. For more information please review our cookie policy.